19-307510-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017550.3(MIER2):c.1225G>A(p.Gly409Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000337 in 1,514,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017550.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIER2 | NM_017550.3 | c.1225G>A | p.Gly409Ser | missense_variant | 13/14 | ENST00000264819.7 | NP_060020.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIER2 | ENST00000264819.7 | c.1225G>A | p.Gly409Ser | missense_variant | 13/14 | 1 | NM_017550.3 | ENSP00000264819.3 | ||
MIER2 | ENST00000619835.4 | c.217G>A | p.Gly73Ser | missense_variant | 3/4 | 3 | ENSP00000482489.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000314 AC: 5AN: 159408Hom.: 0 AF XY: 0.0000348 AC XY: 3AN XY: 86248
GnomAD4 exome AF: 0.0000338 AC: 46AN: 1362296Hom.: 0 Cov.: 32 AF XY: 0.0000329 AC XY: 22AN XY: 668238
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.1225G>A (p.G409S) alteration is located in exon 13 (coding exon 13) of the MIER2 gene. This alteration results from a G to A substitution at nucleotide position 1225, causing the glycine (G) at amino acid position 409 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at